Cargando…

Design, Synthesis and Anti-Tubercular Activity of Novel 1, 4-Dihydropyrine-3, 5-Dicarboxamide Containing 4(5)-Chloro-2-Ethyl- 5(4)-Imidazolyl Moiety

Current researches have showed that N3, N5-diaryl-2, 6-dimethyl -1, 4-dihydropyrine-3, 5- dicarboxamide analogues demonstrate notable anti-tubercular activity. In this study, Hantzsch condensation was used to design and synthesize new analogues of dihydropyridine (DHP). Different diary carboxamides...

Descripción completa

Detalles Bibliográficos
Autores principales: Iman, Maryam, Davood, Asghar, Lotfinia, Mahboubeh, Dehqani, Golnoush, Sardari, Soroush, Azerang, Parisa, Amini, Mohsen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shaheed Beheshti University of Medical Sciences 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5316257/
https://www.ncbi.nlm.nih.gov/pubmed/28243275
_version_ 1782508817209098240
author Iman, Maryam
Davood, Asghar
Lotfinia, Mahboubeh
Dehqani, Golnoush
Sardari, Soroush
Azerang, Parisa
Amini, Mohsen
author_facet Iman, Maryam
Davood, Asghar
Lotfinia, Mahboubeh
Dehqani, Golnoush
Sardari, Soroush
Azerang, Parisa
Amini, Mohsen
author_sort Iman, Maryam
collection PubMed
description Current researches have showed that N3, N5-diaryl-2, 6-dimethyl -1, 4-dihydropyrine-3, 5- dicarboxamide analogues demonstrate notable anti-tubercular activity. In this study, Hantzsch condensation was used to design and synthesize new analogues of dihydropyridine (DHP). Different diary carboxamides were inserted at positions 3 and 5 of the DHP ring. 4(5)-chloro-2-ethyl-5(4)-imidazolyl moiety was considered at position 4 of the DHP ring. The structures of prepared ligands were characterized using TLC followed by FT-IR, elemental analysis, Mass and proton NMR. Results of anti-tubercular activity have indicated all the prepared ligands 3a-f inhibit the mycobacterium tuberculosis growth and the most potent compounds were 3c (3,4-Cl) and 3b (4-Cl). The in-vitro obtained data are agreement with our computational predictions in terms of partial atomic charge of carbonyl moieties at the positions 3 and 5 of dihydropyridine ring and the logP of the molecules.
format Online
Article
Text
id pubmed-5316257
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Shaheed Beheshti University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-53162572017-02-27 Design, Synthesis and Anti-Tubercular Activity of Novel 1, 4-Dihydropyrine-3, 5-Dicarboxamide Containing 4(5)-Chloro-2-Ethyl- 5(4)-Imidazolyl Moiety Iman, Maryam Davood, Asghar Lotfinia, Mahboubeh Dehqani, Golnoush Sardari, Soroush Azerang, Parisa Amini, Mohsen Iran J Pharm Res Original Article Current researches have showed that N3, N5-diaryl-2, 6-dimethyl -1, 4-dihydropyrine-3, 5- dicarboxamide analogues demonstrate notable anti-tubercular activity. In this study, Hantzsch condensation was used to design and synthesize new analogues of dihydropyridine (DHP). Different diary carboxamides were inserted at positions 3 and 5 of the DHP ring. 4(5)-chloro-2-ethyl-5(4)-imidazolyl moiety was considered at position 4 of the DHP ring. The structures of prepared ligands were characterized using TLC followed by FT-IR, elemental analysis, Mass and proton NMR. Results of anti-tubercular activity have indicated all the prepared ligands 3a-f inhibit the mycobacterium tuberculosis growth and the most potent compounds were 3c (3,4-Cl) and 3b (4-Cl). The in-vitro obtained data are agreement with our computational predictions in terms of partial atomic charge of carbonyl moieties at the positions 3 and 5 of dihydropyridine ring and the logP of the molecules. Shaheed Beheshti University of Medical Sciences 2016 /pmc/articles/PMC5316257/ /pubmed/28243275 Text en © 2016 by School of Pharmacy Shaheed Beheshti University of Medical Sciences and Health Services This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Iman, Maryam
Davood, Asghar
Lotfinia, Mahboubeh
Dehqani, Golnoush
Sardari, Soroush
Azerang, Parisa
Amini, Mohsen
Design, Synthesis and Anti-Tubercular Activity of Novel 1, 4-Dihydropyrine-3, 5-Dicarboxamide Containing 4(5)-Chloro-2-Ethyl- 5(4)-Imidazolyl Moiety
title Design, Synthesis and Anti-Tubercular Activity of Novel 1, 4-Dihydropyrine-3, 5-Dicarboxamide Containing 4(5)-Chloro-2-Ethyl- 5(4)-Imidazolyl Moiety
title_full Design, Synthesis and Anti-Tubercular Activity of Novel 1, 4-Dihydropyrine-3, 5-Dicarboxamide Containing 4(5)-Chloro-2-Ethyl- 5(4)-Imidazolyl Moiety
title_fullStr Design, Synthesis and Anti-Tubercular Activity of Novel 1, 4-Dihydropyrine-3, 5-Dicarboxamide Containing 4(5)-Chloro-2-Ethyl- 5(4)-Imidazolyl Moiety
title_full_unstemmed Design, Synthesis and Anti-Tubercular Activity of Novel 1, 4-Dihydropyrine-3, 5-Dicarboxamide Containing 4(5)-Chloro-2-Ethyl- 5(4)-Imidazolyl Moiety
title_short Design, Synthesis and Anti-Tubercular Activity of Novel 1, 4-Dihydropyrine-3, 5-Dicarboxamide Containing 4(5)-Chloro-2-Ethyl- 5(4)-Imidazolyl Moiety
title_sort design, synthesis and anti-tubercular activity of novel 1, 4-dihydropyrine-3, 5-dicarboxamide containing 4(5)-chloro-2-ethyl- 5(4)-imidazolyl moiety
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5316257/
https://www.ncbi.nlm.nih.gov/pubmed/28243275
work_keys_str_mv AT imanmaryam designsynthesisandantitubercularactivityofnovel14dihydropyrine35dicarboxamidecontaining45chloro2ethyl54imidazolylmoiety
AT davoodasghar designsynthesisandantitubercularactivityofnovel14dihydropyrine35dicarboxamidecontaining45chloro2ethyl54imidazolylmoiety
AT lotfiniamahboubeh designsynthesisandantitubercularactivityofnovel14dihydropyrine35dicarboxamidecontaining45chloro2ethyl54imidazolylmoiety
AT dehqanigolnoush designsynthesisandantitubercularactivityofnovel14dihydropyrine35dicarboxamidecontaining45chloro2ethyl54imidazolylmoiety
AT sardarisoroush designsynthesisandantitubercularactivityofnovel14dihydropyrine35dicarboxamidecontaining45chloro2ethyl54imidazolylmoiety
AT azerangparisa designsynthesisandantitubercularactivityofnovel14dihydropyrine35dicarboxamidecontaining45chloro2ethyl54imidazolylmoiety
AT aminimohsen designsynthesisandantitubercularactivityofnovel14dihydropyrine35dicarboxamidecontaining45chloro2ethyl54imidazolylmoiety